Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Chronic Obstructive Pulmonary Disease”

411 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 411 results

Testing effectiveness (Phase 2)Ended earlyNCT00706914
What this trial is testing

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
AstraZeneca 156
Not applicableStudy completedNCT06269029
What this trial is testing

Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease Moderate
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT05987371
What this trial is testing

A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT00485225
What this trial is testing

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Who this might be right for
Chronic, Non Malignant Pain
Durect 77
Very early researchUnknownNCT05539547
What this trial is testing

Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereAcute Exacerbation of COPD
Randall Debattista 140
Large-scale testing (Phase 3)Study completedNCT02343458
What this trial is testing

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 1,756
Testing effectiveness (Phase 2)Ended earlyNCT00263874
What this trial is testing

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Pfizer 324
Post-approval studies (Phase 4)Study completedNCT01272362
What this trial is testing

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 625
Early research (Phase 1)WithdrawnNCT01009424
What this trial is testing

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Hoffmann-La Roche
Large-scale testing (Phase 3)UnknownNCT03745261
What this trial is testing

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Henan University of Traditional Chinese Medicine 240
Testing effectiveness (Phase 2)Study completedNCT00758459
What this trial is testing

Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 74
Early research (Phase 1)Study completedNCT01483534
What this trial is testing

Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Nuvaira, Inc. 22
Post-approval studies (Phase 4)Study completedNCT03964207
What this trial is testing

A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 72
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Testing effectiveness (Phase 2)Study completedNCT02971293
What this trial is testing

Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

Who this might be right for
Chronic Obstructive Pulmonary Disease COPD
AstraZeneca 42
Testing effectiveness (Phase 2)Study completedNCT03123692
What this trial is testing

NBMI - Clinical Study on COPD

Who this might be right for
COPDCOPD Bronchitis
EmeraMed 12
Large-scale testing (Phase 3)Study completedNCT02268396
What this trial is testing

Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD

Who this might be right for
COPD
Pearl Therapeutics, Inc. 138
Large-scale testing (Phase 3)Study completedNCT01727141
What this trial is testing

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,042
Large-scale testing (Phase 3)WithdrawnNCT01837927
What this trial is testing

Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Novartis Pharmaceuticals
Not applicableUnknownNCT06142266
What this trial is testing

Functional Status in COPD Patients After Exercise Rehabilitation Program

Who this might be right for
Copd
Assiut University 120
Load More Results